Finance

Beta
Lists
524703:BOM
Sandu Pharmaceuticals Ltd
₹42.50
-2.52%
(-1.10) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524703...
Open
₹43.59
High
₹43.60
Low
₹42.14
Mkt. cap
410.59M
Avg. vol.
11.01K
Volume
535.00
P/E ratio
23.22
52-wk high
₹58.28
52-wk low
₹30.00
EPS
₹1.83
No. of employees
303
Open
₹43.59
High
₹43.60
Low
₹42.14
Mkt. cap
410.59M
Avg. vol.
11.01K
Volume
535.00
P/E ratio
23.22
52-wk high
₹58.28
52-wk low
₹30.00
EPS
₹1.83
No. of employees
303
News stories
From sources across the web
About Sandu Pharmaceuticals Ltd
CEO-
Employees303
Founded1899
Headquarters-
SectorPersonal care products
Websitesandu.in
Last report
May 5, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
168.53M / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
166.99M
176.21M
187.61M
168.53M
Cost of goods sold
88.33M
83.27M
78.87M
65.25M
Cost of revenue
88.33M
83.27M
78.87M
65.25M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.64M
26.38M
26.46M
27.43M
Operating expense
75.18M
86.01M
99.99M
99.21M
Total operating expenses
163.52M
169.28M
178.86M
164.46M
Operating income
3.48M
6.93M
8.75M
4.08M
Other non operating income
176.00K
480.00K
137.00K
3.65M
EBT including unusual items
3.39M
7.15M
8.55M
7.47M
EBT excluding unusual items
3.39M
7.15M
8.55M
7.47M
Income tax expense
1.15M
1.90M
-1.20M
7.04M
Effective tax rate
34.07%
26.63%
-14.05%
94.19%
Other operating expenses
46.77M
57.94M
71.87M
70.13M
Net income
2.23M
5.24M
9.75M
434.00K
Net profit margin
1.34%
2.98%
5.20%
0.26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-264.00K
-266.00K
-335.00K
-256.00K
Net interest expenses
-264.00K
-266.00K
-335.00K
-256.00K
Depreciation and amortization charges
1.78M
1.69M
1.66M
1.65M
EBITDA
5.15M
8.66M
9.86M
5.77M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer